Enhancing neurite growth and neural functions on polymeric nerve conduit with BMSC-derived ECM coating.
Miaoben WuHaiyang WangKailei XuJin MeiZonghuan WangPublished in: Biomedical materials (Bristol, England) (2024)
The therapy of large defects in peripheral nerve injury (PNI) suffers from several drawbacks, especially the lack of autologous nerve donors. Nerve conduits are considered as a solution for nerve injury treatment, but biocompatibility improvements is still required for conduits prepared with synthetic materials. Cell-derived extracellular matrix (ECM) has drawn attention due to its lower risk of immunogenic response and independence from donor availability. The goal of this study is to coat bone mesenchymal stem cell (BMSC)-derived ECMs on poly(lactic-co-glycolic) acid (PLGA) conduits to enhance their ability to support neural growth and neurite extensions. The ECM-coated conduits have better hydrophilic properties than the pure PLGA conduits. A marked increase on PC12 and RSC96 cells' viability, proliferation and dorsal root ganglion neurite extension was observed. Quantitative PCR analysis exhibited a significant increase in markers for cell proliferation (GAP43), neurite extension (NF-H, MAP2, and βIII-tubulin) and neural function (TREK-1). These results show the potential of ECM-coated PLGA conduits in PNI therapy.
Keyphrases
- extracellular matrix
- peripheral nerve
- drug delivery
- drug release
- cell proliferation
- signaling pathway
- bone regeneration
- mesenchymal stem cells
- bone marrow
- induced apoptosis
- neuropathic pain
- spinal cord
- oxidative stress
- working memory
- pi k akt
- cancer therapy
- bone mineral density
- cell cycle
- climate change
- cell cycle arrest
- spinal cord injury
- risk assessment
- nuclear factor
- kidney transplantation
- optical coherence tomography
- replacement therapy
- platelet rich plasma
- body composition
- liquid chromatography
- simultaneous determination
- real time pcr